Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1986 1
2002 1
2003 2
2005 3
2006 3
2007 1
2008 1
2009 1
2010 5
2011 6
2012 2
2013 10
2014 9
2015 12
2016 7
2017 9
2018 7
2019 7
2020 6
2021 6
2022 7
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for kristy p
Search for Kirsty P instead (1 results)
Primary Nonadherence to Overactive Bladder Medications in an Integrated Managed Care Health Care System.
Rashid N, Vassilakis M, Lin KJ, Kristy R, Ng DB. Rashid N, et al. J Manag Care Spec Pharm. 2017 Apr;23(4):484-493. doi: 10.18553/jmcp.2017.23.4.484. J Manag Care Spec Pharm. 2017. PMID: 28345439 Free PMC article.

They also had lower mean Charlson Comorbidity Index (CCI) scores (1.99 vs. 2.70; P < 0.001), fewer OAB-related comorbidities, fewer concomitant medications (P < 0.005), and fewer overall prescriptions dispensed in the previous 12 months (P < 0.001) c

They also had lower mean Charlson Comorbidity Index (CCI) scores (1.99 vs. 2.70; P < 0.001), fewer OAB-related comorbidities, fewe

Robust estimation of bacterial cell count from optical density.
Beal J, Farny NG, Haddock-Angelli T, Selvarajah V, Baldwin GS, Buckley-Taylor R, Gershater M, Kiga D, Marken J, Sanchania V, Sison A, Workman CT; iGEM Interlab Study Contributors. Beal J, et al. Commun Biol. 2020 Sep 17;3(1):512. doi: 10.1038/s42003-020-01127-5. Commun Biol. 2020. PMID: 32943734 Free PMC article.
Impact of Overactive Bladder Step Therapy Policies on Medication Utilization and Expenditures Among Treated Medicare Members.
Abbass IM, Caplan EO, Ng DB, Kristy R, Schermer CR, Bradt P, Collins JM, Chan WM, Suehs BT. Abbass IM, et al. J Manag Care Spec Pharm. 2017 Jan;23(1):27-37. doi: 10.18553/jmcp.2017.23.1.27. J Manag Care Spec Pharm. 2017. PMID: 28025920 Free PMC article.

RESULTS: Of 194,511 patients, trends in utilization of OAB medications indicated that on average, there was a statistically significant monthly increase in utilization of mirabegron (regression coefficient [B] = 274; P < 0.001; 95% CI: 218, 330), fesoterodine (B = 167;

RESULTS: Of 194,511 patients, trends in utilization of OAB medications indicated that on average, there was a statistically significant mont …
Genome-wide association studies identify novel loci in rapidly progressive Alzheimer's disease.
Wang P, Lynn A, Miskimen K, Song YE, Wisniewski T, Cohen M, Appleby BS, Safar JG, Haines JL. Wang P, et al. Alzheimers Dement. 2024 Mar;20(3):2034-2046. doi: 10.1002/alz.13655. Epub 2024 Jan 7. Alzheimers Dement. 2024. PMID: 38184787 Free PMC article.

Compared to the clinical cohort, pathology-confirmed rpAD had higher frequencies of apolipoprotein E (APOE) epsilon4 and rare missense variants in AD risk genes. A novel genome-wide significant locus (P < 510(-8) ) was observed for clinical rpAD on chromosome 21 (rs2832

Compared to the clinical cohort, pathology-confirmed rpAD had higher frequencies of apolipoprotein E (APOE) epsilon4 and rare missense varia …
Panobinostat: A histone deacetylase inhibitor for the treatment of relapsed or refractory multiple myeloma.
Wahaib K, Beggs AE, Campbell H, Kodali L, Ford PD. Wahaib K, et al. Am J Health Syst Pharm. 2016 Apr 1;73(7):441-50. doi: 10.2146/ajhp150487. Am J Health Syst Pharm. 2016. PMID: 27001985 Review.
A Phase III trial comparing panobinostat or placebo use in combination with bortezomib and dexamethasone demonstrated improved median progression-free survival in the panobinostat group (11.99 months [95% CI, 10.33-12.94 months] versus 8.08 months [95% CI, 7.56-9.23 months]; haza …
A Phase III trial comparing panobinostat or placebo use in combination with bortezomib and dexamethasone demonstrated improved median progre …
Using quantitative disease dynamics as a tool for guiding response to avian influenza in poultry in the United States of America.
Pepin KM, Spackman E, Brown JD, Pabilonia KL, Garber LP, Weaver JT, Kennedy DA, Patyk KA, Huyvaert KP, Miller RS, Franklin AB, Pedersen K, Bogich TL, Rohani P, Shriner SA, Webb CT, Riley S. Pepin KM, et al. Prev Vet Med. 2014 Mar 1;113(4):376-97. doi: 10.1016/j.prevetmed.2013.11.011. Epub 2013 Dec 1. Prev Vet Med. 2014. PMID: 24462191 Free PMC article. Review.
104 results